Cristina M. Furdui, PhD, is Professor in the Department of Internal Medicine, Section on Molecular Medicine with joint appointments in the Departments of Biochemistry and Cancer Biology. Her academic involvement extends to being an affiliate faculty member at both the Maya Angelou Center for Health Equity and Wake Forest University's Department of Chemistry. In her capacity, Dr. Furdui assumes the roles of Co-Director of the Center for Redox Biology and Medicine and of the associated NIH T32 graduate training program, scientific Director of the Proteomics and Metabolomics Shared Resource, and as Co-Leader of the Atrium Health Wake Forest Baptist Comprehensive Cancer Center - Cancer Genetics and Metabolism Program. Her responsibilities encompass advancing the educational and research objectives of these programs and engaging in her own investigative endeavors.

In her role as Vice Dean for Basic and Pre-Clinical Science, Dr. Furdui is charged with the development and advancement of basic and pre-clinical research-focused strategic initiatives and programs, aimed at bolstering the research and educational pursuits of the departments, centers, and institutes. Her objectives include ensuring the translation of research findings into enhanced patient care, in alignment with the institution's "cells to communities" framework, collaborating with leadership to allocate resources to bolster pre-clinical science faculty, staff, and students, and furthering WFUSM's commitment to diversity, equity, inclusion, and justice in its research environment and programs.
 
Renowned internationally for her expertise in redox mechanisms of disease, Dr. Furdui's laboratory integrates chemical and systems biology methodologies to explore redox processes pertinent to human health. With a rich background spanning over two decades in biomedical research, she has chaired esteemed international conferences in the field, such as the Gordon Research Conference on Thiol-Based Redox Regulation & Signaling. Her scholarly contributions include an extensive array of publications (>130), book chapters, and several patented technologies. Since joining the faculty in 2006, following postdoctoral training at Yale University School of Medicine, her research team has consistently received funding from the National Institutes of Health and various foundations. Presently, she serves as Principal Investigator on three NIH grants and as a co-investigator on multiple team science projects, with substantial cumulative funding of over 30 million dollars. Dr. Furdui's group is also actively involved in numerous collaborative research projects within the institution and with external universities, including Historically Black Colleges and Universities (HBCUs), spanning diverse research domains.